Related Experiment Videos
Metabolic burden is independently and linearly associated with lower testosterone levels: evidence from NHANES
1Department of Urology, Istanbul Beykent University, Istanbul, Türkiye.
Objectives:
Testosterone deficiency and metabolic dysfunction frequently coexist in aging men; however, whether metabolic impairment is associated with a progressive decline in testosterone across the metabolic spectrum remains unclear.
Methods:
We analyzed 2,192 U.S. men aged ≥40 years from the National Health and Nutrition Examination Survey (NHANES). Metabolic burden was assessed using the triglyceride-glucose (TyG) index. Survey-weighted linear regression models were used to evaluate the association between TyG and log-transformed total testosterone after adjustment for age, HDL cholesterol, diabetes, and smoking. Dose-response relationships were further examined using quartiles and restricted cubic spline analyses.
Results:
Higher TyG levels were independently associated with lower testosterone concentrations. In fully adjusted models, each 1-unit increase in TyG was associated with an approximately 12 % decrease in testosterone (p<0.001). Compared with the lowest TyG quartile, men in the highest quartile had approximately 19 % lower testosterone levels. Spline analysis demonstrated a consistent inverse association without significant nonlinearity (p for nonlinearity=0.21), supporting a graded and continuous relationship across the metabolic spectrum.
Conclusions:
Higher metabolic burden was independently associated with lower total testosterone levels in middle-aged and older men. However, due to the cross-sectional design and absence of SHBG/free testosterone measurements, these findings should be interpreted cautiously and require confirmation in longitudinal studies.
Related Concept Videos
Metabolic Rate
The Basal Metabolic Rate (BMR) measures the energy expended at rest.
Several factors influence the...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Testosterone: Functions and Regulation
Regression Toward the Mean
Type II Diabetes I: Introduction
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution